Codagenix Expands Senior Management Team With Three New Appointments
Codagenix Expands Senior Management Team With Three New Appointments New Hires Bolster Codagenix's Operations, Regulatory Affairs and Clinical Trial Management News provided by Share this article Share this article NEW YORK, March 17, 2021 /PRNewswire/ -- Codagenix Inc., a clinical-stage biotechnology company developing prophylactic vaccines and oncolytic virus therapies, today announced the expansion of its senior management team with three new appointments. Lisa Runco, Ph.D., has been named Director of Operations. Additionally, Sally Yang, M.S., R.A.C. has been appointed Associate Director...
Source: prnewswire.com